| Bioactivity | Pharmacokinetic studies of Cefonicid have shown that high blood concentrations can be achieved rapidly after intravenous and intramuscular injection, and that concomitant use of albendazole prolongs its half-life in the body and reduces the rate of renal excretion[1]. |
| CAS | 61270-58-4 |
| Formula | C18H18N6O8S3 |
| Molar Mass | 542.57 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Pitkin D, et al. Kinetics and renal handling of cefonicid[J]. Clinical Pharmacology & Therapeutics, 1981, 30(5): 587-593. |
Cefonicid
CAS: 61270-58-4 F: C18H18N6O8S3 W: 542.57
Pharmacokinetic studies of Cefonicid have shown that high blood concentrations can be achieved rapidly after intravenous
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.